Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fat Digestion”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02010034
What this trial is testing

Compassionate Use of Omegaven in the Treatment of Parenteral Nutrition Induced Hepatic Injury

Who this might be right for
Liver DiseaseImpaired Liver FunctionParenteral Nutrition Associated Liver Disease
Children's Medical Center Dallas 15
Not applicableStudy completedNCT05309642
What this trial is testing

Nonalcoholic Fatty Liver Disease - Intermittent Calorie Restriction (FLICR) Study

Who this might be right for
Nonalcoholic Fatty LiverNonalcoholic Steatohepatitis
Ewha Womans University Mokdong Hospital 72
Not applicableStudy completedNCT01446276
What this trial is testing

Long-term Investigation of Resveratrol on Fat Metabolism in Obese Men With Nonalcoholic Fatty Liver Disease

Who this might be right for
ObesityNonalcoholic Fatty Liver Disease
University of Aarhus 26
Early research (Phase 1)Looking for participantsNCT04715191
What this trial is testing

Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

Who this might be right for
Liver CancerRhabdomyosarcomaMalignant Rhabdoid Tumor+3 more
Baylor College of Medicine 24
Not applicableStudy completedNCT03593343
What this trial is testing

Hepatic Glycogen and Fat Oxidation

Who this might be right for
Fatty Liver, NonalcoholicMeal TimeFasting+1 more
Maastricht University Medical Center 11
Testing effectiveness (Phase 2)UnknownNCT02574325
What this trial is testing

Assess ARI-3037MO on Hepatic Fat Metabolism in Patients With Dysglycemia and Evidence of Hepatic Steatosis

Who this might be right for
Nonalcoholic Steatohepatitis
Arisaph Pharmaceuticals Inc 11
Not applicableStudy completedNCT03200457
What this trial is testing

Comparison of the Variability of Hepatic Load Quantification in Iron and Fat Estimated by MRI at 1.5 and 3 Tesla

Who this might be right for
Iron Hepatic OverloadFat Hepatic Overload
Rennes University Hospital 92
Early research (Phase 1)Active Not RecruitingNCT04377932
What this trial is testing

Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors

Who this might be right for
Liver CancerRhabdomyosarcomaMalignant Rhabdoid Tumor+3 more
Baylor College of Medicine 14
Testing effectiveness (Phase 2)Study completedNCT04618744
What this trial is testing

Assess the Safety and Efficacy of Oral Insulin in T2DM Patients With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Diabetes Mellitus, Type 2NASH - Nonalcoholic Steatohepatitis
Oramed, Ltd. 32
Not applicableUnknownNCT04415632
What this trial is testing

Low GI Diet Effects on Non-Alcoholic Fatty Liver Disease

Who this might be right for
Fatty LiverNutritional and Metabolic Disease
University of Nottingham 16
Not applicableStudy completedNCT02682173
What this trial is testing

Magnetic Resonance Imaging (MRI) Fat Quantification of the Liver

Who this might be right for
Non-alcoholic Fatty Liver DiseaseObesity
University Hospital, Basel, Switzerland 15
Not applicableUnknownNCT04240145
What this trial is testing

Non Alcoholic Steatohepatitis in Relation to Visceral and Subcutaneous Fat

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Gehad Abd Elaziz Mhmoud Ahmad 35
Post-approval studies (Phase 4)Looking for participantsNCT03851627
What this trial is testing

Effects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Overweight/Obese Men With T2DM or Prediabetes and Hypogonadism

Who this might be right for
Fatty LiverOverweight/ObesityPrediabetes/Type2 Diabetes Mellitus+1 more
Alexandra Kautzky-Willer 32
Not applicableStudy completedNCT02204670
What this trial is testing

EXIT: Prospective Study of the Response to Exercise

Who this might be right for
Liver FatType 2 Diabetes
University of Manitoba 15
Post-approval studies (Phase 4)Study completedNCT04642261
What this trial is testing

Effect of Empagliflozin on Liver Fat in Non-diabetic Patients

Who this might be right for
Non-alcoholic Fatty Liver Disease
The University of Hong Kong 98
Not applicableStudy completedNCT03883464
What this trial is testing

Quality of Life Related to Digestive Symptoms After Cholecistectomy. Short Term Effects of a Low Fat Intake.

Who this might be right for
DyspepsiaPostoperative ComplicationsQuality of Life
Consorci Sanitari de Terrassa 160
Testing effectiveness (Phase 2)Study completedNCT03371355
What this trial is testing

Study of ISIS 703802 in Participants With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease

Who this might be right for
NAFLDDiabetes Mellitus, Type 2Hypertriglyceridemia+1 more
Akcea Therapeutics 105
Post-approval studies (Phase 4)Study completedNCT05647915
What this trial is testing

Effects of Berberine in Reducing Abdominal Visceral Adipose Tissue Among Individuals with Obesity and NAFLD

Who this might be right for
ObesityObesity, AbdominalNAFLD
China National Center for Cardiovascular Diseases 337
Not applicableStudy completedNCT04644887
What this trial is testing

Liver, Diet and Genetic Background

Who this might be right for
Liver Fat
University of Eastern Finland 99
Post-approval studies (Phase 4)Study completedNCT02875821
What this trial is testing

Effects of Ipragliflozin on Excessive Fat in Type 2 Diabetes Patients With Non-alcoholic Fatty Liver Disease Treated With Metformin and Pioglitazone

Who this might be right for
Type 2 Diabetes With Non-alcoholic Fatty Liver (NAFLD)
Yonsei University 44
Next Page